Cullinan Therapeutics Cash from Investing (TTM) Analysis

Cullinan Therapeutics Inc (CGEM)

16.81 +1.18 (+7.55%) USD | NASDAQ | Apr 23, 13:32

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	35.81M
September 30, 2023	-44.27M
June 30, 2023	-59.29M
March 31, 2023	229.45M
December 31, 2022	248.98M
September 30, 2022	261.72M
June 30, 2022	294.11M

Date	Value
March 31, 2022	-161.34M
December 31, 2021	-333.78M
September 30, 2021	-306.47M
June 30, 2021	-282.82M
March 31, 2021	-116.26M
December 31, 2020	-5.42M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-333.78M

Minimum

Dec 2021

294.11M

Maximum

Jun 2022

-18.43M

Average

-44.27M

Median

Sep 2023

Cash from Investing (TTM) Benchmarks